Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1976-02-26
1977-01-11
Jiles, Henry R.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
2602393P, C07D49108
Patent
active
040027520
ABSTRACT:
Novel rifamycins characterized by the following structural formula ##STR1## WHEREIN Me represents a methyl group, n represents 3, 4, 5 or 6; g represents 0, 1 or 2; and each R represents a lower alkyl group selected from methyl or ethyl substituting for a hydrogen atom of a --CH.sub.2 -- group; and wherein, when g is 2, the two lower alkyl groups may replace hydrogen atoms of two different methylene groups as well as hydrogen atoms of the same methylene group. The compounds of this invention possess a broad spectrum antibacterial utility accompanied by a low toxicity.
REFERENCES:
patent: 3342810 (1967-09-01), Maggi et al.
Arioli Vittorio
Cricchio Renato
Bjork C. Kenneth
Bond Robert T.
Gruppo Lepetit S.p.A.
Jiles Henry R.
Post Theodore
LandOfFree
Piperazinylimino rifamycins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperazinylimino rifamycins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperazinylimino rifamycins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1743943